Vorinostat Completed Phase 1 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00045006Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer